Capital Point is an investment company traded on the Tel Aviv Stock Exchange with a portfolio of more than 30 companies at different development stages. The company has accumulated vast experience in the process of screening, evaluating, and mentoring early-stage companies. Capital Point was originally focused on early-stage science-based companies and managed two technology incubators. In 2012, it decided to diversify its portfolio and to be more opportunity oriented, adding significant value to its portfolio to the benefit of shareholders in the short, medium, and long-range. As of today, Capital Point makes investments in the field Biomed and other life sciences technologies.